1.Nanoparticle-Based Chimeric Antigen Receptor Therapy for Cancer Immunotherapy
Seungyong SHIN ; Pyunghwajun LEE ; Jieun HAN ; Se-Na KIM ; Jaesung LIM ; Dae-Hwan PARK ; Taejong PAIK ; Junhong MIN ; Chun Gwon PARK ; Wooram PARK
Tissue Engineering and Regenerative Medicine 2023;20(3):371-387
Adoptive cell therapy with chimeric antigen receptor (CAR)-engineered T cells (CAR-Ts) has emerged as an innovative immunotherapy for hematological cancer treatment. However, the limited effect on solid tumors, complex processes, and excessive manufacturing costs remain as limitations of CAR-T therapy. Nanotechnology provides an alternative to the conventional CAR-T therapy. Owing to their unique physicochemical properties, nanoparticles can not only serve as a delivery platform for drugs but also target specific cells. Nanoparticle-based CAR therapy can be applied not only to T cells but also to CAR-natural killer and CAR-macrophage, compensating for some of their limitations. This review focuses on the introduction of nanoparticle-based advanced CAR immune cell therapy and future perspectives on immune cell reprogramming.
2.Potential benefit of superior to inferior dissection during laparoscopic extended right hemicolectomy
Journal of Minimally Invasive Surgery 2022;25(4):129-130
Various approaches can be used for performing laparoscopic right hemicolectomy for right-sided colon cancer. However, laparoscopic complete mesocolic excision with central vessel ligation using these approaches may sometimes present with difficulties of various factors. This video article presents a laparoscopic extended right hemicolectomy using a superior-to-inferior approach. The superior approach has potential benefits in that it exposes the superior mesenteric vessels and gastrocolic trunk.
3.Validation of the Osteomyelitis Induced by Methicillin-Resistant Staphylococcus aureus (MRSA) on Rat Model with Calvaria Defect
Young Suk CHOI ; Dae Sung HAM ; Ji Yun LIM ; Young Koo LEE
Tissue Engineering and Regenerative Medicine 2021;18(4):671-683
Background:
Osteomyelitis resulting from bacterial strains, such as methicillin-resistant Staphylococcus aureus (MRSA) that are resistant to multiple drugs, brings further clinical challenges. There is currently no model of osteomyelitis induced by MRSA using rats with calvaria defects. So, We induced osteomyelitis in rat models with the calvaria bone defect.
Methods:
The rats were randomly divided into six groups according to inoculation dose levels, which ranged from 6 × 100 to 6 × 105 CFU/5 µl. Bone tissues were retrieved from all rats used in the study and assessed using histology, microbiology, and radiobiology 4 weeks after surgery to evaluate the relationship between inoculation dose and infectivity.
Results:
In Histological results, high levels of inflammatory responses, bone necrosis, and bacteria were observed in treatment groups G3 to G5. In IHC staining, high levels of cox-2 expression were observed in treatment groups G3. Microbiological observations also indicated that significantly higher numbers of CFUs were found in G3 to G5. In radiography results, the bone mineral density in G3 to G5 was significantly higher than in the control group, G1, and G2. Our results indicate that an inoculating dose of 6 × 103 CFU/5 μl is sufficient to induce the development of osteomyelitis in rat models.
Conclusion
This study suggests that the minimum dose (6 × 103CFU/5 µl) can induce osteomyelitis in calvaria rat model. This can offer information and ability of more accurately modeling osteomyelitis and simulating the challenge of osteomyelitis treat.
4.Validation of the Osteomyelitis Induced by Methicillin-Resistant Staphylococcus aureus (MRSA) on Rat Model with Calvaria Defect
Young Suk CHOI ; Dae Sung HAM ; Ji Yun LIM ; Young Koo LEE
Tissue Engineering and Regenerative Medicine 2021;18(4):671-683
Background:
Osteomyelitis resulting from bacterial strains, such as methicillin-resistant Staphylococcus aureus (MRSA) that are resistant to multiple drugs, brings further clinical challenges. There is currently no model of osteomyelitis induced by MRSA using rats with calvaria defects. So, We induced osteomyelitis in rat models with the calvaria bone defect.
Methods:
The rats were randomly divided into six groups according to inoculation dose levels, which ranged from 6 × 100 to 6 × 105 CFU/5 µl. Bone tissues were retrieved from all rats used in the study and assessed using histology, microbiology, and radiobiology 4 weeks after surgery to evaluate the relationship between inoculation dose and infectivity.
Results:
In Histological results, high levels of inflammatory responses, bone necrosis, and bacteria were observed in treatment groups G3 to G5. In IHC staining, high levels of cox-2 expression were observed in treatment groups G3. Microbiological observations also indicated that significantly higher numbers of CFUs were found in G3 to G5. In radiography results, the bone mineral density in G3 to G5 was significantly higher than in the control group, G1, and G2. Our results indicate that an inoculating dose of 6 × 103 CFU/5 μl is sufficient to induce the development of osteomyelitis in rat models.
Conclusion
This study suggests that the minimum dose (6 × 103CFU/5 µl) can induce osteomyelitis in calvaria rat model. This can offer information and ability of more accurately modeling osteomyelitis and simulating the challenge of osteomyelitis treat.
5.Comparison of oncologic outcome of abdominoperineal resection versus sphincter saving resection for low lying rectal cancer
Won Il JO ; Dae Ro LIM ; Jung Cheol KUK ; Eung Jin SHIN
Korean Journal of Clinical Oncology 2021;17(2):73-81
Purpose:
The present study compares the peri/postoperative and oncological outcomes of abdominoperineal resections (APR) and sphincter saving resection (SSR) for low lying rectal cancer.
Methods:
Between January 2001 and December 2014, 176 patients who underwent SSR (n = 67) and APR (n = 109) for low rectal cancer, without stage IV, were retrieved from a retrospective database.
Results:
With a median follow-up of 66.5 months. The mean total number of harvested lymph nodes was 16.7 (SSR) versus 17.1 (APR) (P = 0.801). The advanced T stage was higher in the APR group (82.6%) versus the SSR group (55.2%) (P = 0.006). The positive rate of lymph nodes after surgery was significantly higher in the APR group (45.9%) versus SSR group (25.4%) (P < 0.05). The 5-year overall survival rates for SSR and APR were 87.3% and 67.6%, respectively (P < 0.005). The 5-year disease-free survival rate (DFS) was 83.6% (SSR) versus 65.5% (APR) (P = 0.002). The recurrence rate was higher in the APR group (34.9%) versus the SSR group (14.9%) (P = 0.004). Local recurrence rate was not different between the two groups. However, distant recurrence rate was significantly higher in the APR group (26.6% vs. 11.9%, P = 0.023). In multivariate analysis, node positive (N0 vs. N1-2) was an independent prognostic factor for DFS (P < 0.005).
Conclusion
Based on the present data, SSR achieved better 5-year oncological outcome than APR. The positive lymph node ratio in the N stage after surgery was higher in the APR group and this seems to have an effect on the oncological outcomes of the APR group.
7.Surgery of multiple lymphangioma in small bowel: a rare case report of chronic gastrointestinal bleeding
Dae Ro LIM ; Jung Cheol KUK ; Taehyung KIM ; Eung Jin SHIN
Annals of Surgical Treatment and Research 2018;94(1):52-56
Small bowel lymphangioma is a rare benign tumor of the lymphatic system, characterized by the presence of dilated lymphatic spaces and significant gastrointestinal bleeding. Small bowel lymphangiomas are rare in adults and case reports are few. Lymphangiomas in the jejunum or ileum are extremely rare and account for less than 1% of all lymphangiomas. The case reported herein is of an older patient (70-year-old male) with melena and chronic anemia (hemoglobin count < 5 g/dL) who had small-sized multiple lymphangiomas in his small bowel (jejunum). Surgical resection was performed after failure of treatment by gastroenteroscopy. Final pathological analysis revealed lymphangioma with thrombus and hemorrhage. After surgery, he no longer had decreased hemoglobin count, nor symptoms of anemia and melena. Also, at the last follow-up visit, the patient's hemoglobin count patient was normal and he returned to normal daily functions.
Adult
;
Anemia
;
Endoscopy
;
Follow-Up Studies
;
Hemorrhage
;
Humans
;
Ileum
;
Jejunum
;
Lymphangioma
;
Lymphatic System
;
Melena
;
Thrombosis
8.Epigenetic inactivation of RUNX3 in colorectal cancer
Eung Jin SHIN ; Han Jo KIM ; Myoung Won SON ; Tae Sung AHN ; Hyun Yong LEE ; Dae Ro LIM ; Sang Byung BAE ; Seob JEON ; Hyungjoo KIM ; Dongjun JEONG ; Moon Soo LEE ; Dong Sun KIM ; Jeong Se NOH ; Moo Jun BAEK
Annals of Surgical Treatment and Research 2018;94(1):19-25
PURPOSE: Emerging evidence indicates that runt-related transcription factor 3 (RUNX3) is an important tumor suppressor gene in several cancer types, including colorectal cancer (CRC). However, the clinical significance of RUNX3 inactivation in CRC remains unclear. The aim of this study was to examine the correlation between clinicopathologic factors and RUNX3 hypermethylation/expression in CRC. METHODS: Sixty-two CRC patients who were treated at the Soonchunhyang University College of Medicine were recruited in this study. The hypermethylation of CpG islands in the RUNX3 promoter and the expression of RUNX3 mRNA were identified by methylation-specific polymerase chain reaction (PCR) and reverse transcriptase-PCR, respectively. The expression of RUNX3 was determined by immunohistochemical staining. RESULTS: Of the 62 CRC tissue samples, 20 (32.3%) presented hypermethylated RUNX3 promoters. Aberrant RUNX3 hypermethylation was found to be associated with vascular (P = 0.006) and lymphatic (P = 0.002) invasion. Hypermethylation of RUNX3 was associated with poor survival outcomes (P = 0.038). However, expression of RUNX3 was not a prognostic factor (P = 0.363). CONCLUSION: Hypermethylation of RUNX3 may be a predictor of a poor prognosis in CRC.
Colorectal Neoplasms
;
Core Binding Factor Alpha 3 Subunit
;
CpG Islands
;
Epigenomics
;
Genes, Tumor Suppressor
;
Humans
;
Immunohistochemistry
;
Methylation
;
Polymerase Chain Reaction
;
Prognosis
;
RNA, Messenger
;
Transcription Factor 3
9.Acute radiation syndrome in a non-destructive testing worker: a case report
Ji Sung AHN ; Jai Dong MOON ; Wonyang KANG ; Hyeong Min LIM ; Seunghyeon CHO ; Dae Young LIM ; Won Ju PARK
Annals of Occupational and Environmental Medicine 2018;30(1):59-
BACKGROUND: In Korea, there were repeated radiation exposure accidents among non-destructive testing workers. Most of the cases involved local injury, such as radiation burns or hematopoietic cancer. Herein, we report a case of acute radiation syndrome caused by short periods of high exposure to ionizing radiation. CASE PRESENTATION: In January 2017, Korea Information System on Occupational Exposure (KISOE) found that a 31-year-old man who had worked in a non-destructive testing company had been overexposed to radiation. The patient complained of symptoms of anorexia, general weakness, prostration, and mild dizziness for several days. He was anemic. The venous injection areas had bruises and bleeding tendency. Blood and bone marrow testing showed pancytopenia and the patient was diagnosed with acute radiation syndrome (white blood cells: 1400/cubic mm, hemoglobin: 7.1 g/dL, platelets: 14000/cubic mm). He was immediately prohibited from working and blood transfusion was commenced. The patient’s radiation exposure dose was over 1.4 Gy (95% confidence limits: 1.1–1.6) in lymphocyte depletion kinetics. It was revealed that the patient had been performing non-destructive tests without radiation shielding when working in high places of the large pipe surface. CONCLUSIONS: Exposure prevention is clearly possible in radiation-exposed workers. Strict legal amendments to safety procedures are essential to prevent repeated radiation exposure accidents.
Acute Radiation Syndrome
;
Adult
;
Anorexia
;
Blood Cells
;
Blood Transfusion
;
Bone Marrow
;
Burns
;
Contusions
;
Dizziness
;
Hemorrhage
;
Humans
;
Information Systems
;
Kinetics
;
Korea
;
Lymphocyte Depletion
;
Occupational Exposure
;
Pancytopenia
;
Radiation Exposure
;
Radiation, Ionizing
10.CORRIGENDUM: Correction of funding statement in ACKNOWLEDGEMENTS section: Epigenetic inactivation of RUNX3 in colorectal cancer.
Eung Jin SHIN ; Han Jo KIM ; Myoung Won SON ; Tae Sung AHN ; Hyun Yong LEE ; Dae Ro LIM ; Sang Byung BAE ; Seob JEON ; Hyungjoo KIM ; Dongjun JEONG ; Moon Soo LEE ; Dong Sun KIM ; Jeong Se NOH ; Moo Jun BAEK
Annals of Surgical Treatment and Research 2018;94(3):166-166
Correction of funding statement in ACKNOWLEDGEMENTS section.

Result Analysis
Print
Save
E-mail